Developer of cell separation technology intended to isolate contaminated cells. The company's technology makes use of a cell isolator device that selectively separates target cells from blood and bone marrow thus separating contaminated cells like red blood cells and platelets for use in infection imaging and tissue regeneration, helping patients with anxiety and other problems.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore MicroMedicine‘s full profile, request access.
Request a free trial